The launch of the U.S POINTER study at AAIC 2017

Laura Baker, PhD from the Wake Forest School of Medicine, Winston-Salem, NC, announces at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK the launch of a new trial in the USA. The $20 million 2 year trial will assess lifestyle intervention to prevent cognitive decline and dementia in 2500 adults who are at increased risk of dementia. This trial is based on the FINGER study in Finland which showed that lifestyle intervention can prevent cognitive decline. This large US study to PrOtect through a lifestyle INTErvention to Reduce risk (U.S. POINTER) will include interventions covering four areas: aerobic exercise, MIND diet, cognitive stimulation and frequent self management of medical co-morbidities. Recruiting will begin in 2018.

Share this video